The effect of testosterone replacement on plasma lipids and apolipoproteins.
Ten men with Klinefelter's syndrome were studied to assess the effect of testosterone replacement on plasma lipids and apolipoproteins. Measurements taken before the insertion of a testosterone ester implant were compared with those obtained 1 week and 4 weeks later. Mean plasma testosterone, androstenedione, total cholesterol and calculated LDL-cholesterol increased significantly after 1 and 4 weeks. No significant changes were seen in total plasma concentrations of HDL-cholesterol, HDL-cholesterol subfractions 2 and 3 or in apoplipoproteins A-I, A-II or B. A significant correlation was seen between total cholesterol and plasma oestradiol concentrations (Rs = 0.61; P less than 0.001). A significant negative correlation was seen between the concentrations of total testosterone and total triglyceride (Rs = -0.56; P less than 0.005) but not with the other lipid parameters. Testosterone replacement is associated with slight but potentially adverse changes in plasma cholesterol levels.
Jones
D B
DB
Department of Medicine, Western General Hospital, Edinburgh, UK.
Higgins
B
B
Billet
J S
JS
Price
W H
WH
Edwards
C R
CR
Beastall
G H
GH
Shepherd
J
J
Sweeting
V M
VM
Horn
D B
DB
Wenham
P R
PR
D000328:Adult; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology; D004967:Estrogens / Q000097:blood; D006801:Humans; D007713:Klinefelter Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008055:Lipids / Q000097:blood*; D008297:Male; D012307:Risk Factors; D013739:Testosterone / Q000097:blood / Q000494:pharmacology*
D001053:Apolipoproteins; D004967:Estrogens; D008055:Lipids; D013739:Testosterone; D002784:Cholesterol